Daozhong Zou

This inventor holds 18 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Signal Pharmaceuticals, Inc., Celgene Car LLC, Celgene Corporation. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daozhong Zou. Retrieved from https://idiyas.com/inventor/daozhong-zou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 4)

% Patents Active = 94.4

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 63(Granted Patents)

Company Filing History:

5 out of 169

Signal Pharmaceuticals, Inc.

Impact Biomedicines, Inc.

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

JAK2 Inhibitor

MK2 Inhibitor

Thiazolidinone Compound

Oxime Ether Compound

Solid Forms

Compositions

Formulations

ERK Inhibitor

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559463 - Crystalline forms of a JAK2 inhibitor (2026-02-24),

2. 12049446 - Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof (2024-07-30),

3. 11958805 - Solid forms comprising an oxime ether compound, compositions and methods of use thereof (2024-04-16),

4. 11629153 - Forms and compositions of a MK2 inhibitor (2023-04-18),

5. 11629124 - Solid forms comprising an oxime ether compound, compositions and methods of use thereof (2023-04-18),

6. 11434200 - Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof (2022-09-06),

7. 11186556 - Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof (2021-11-30),

8. 11014897 - Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof (2021-05-25),

9. 11013723 - Solid forms of a thiazolidinone compound, compositions and methods of use thereof (2021-05-25),

10. 10882867 - Forms and compositions of a MK2 inhibitor (2021-01-05),

11. 10590089 - Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide (2020-03-17),

12. 10202364 - Forms and compositions of an ERK inhibitor (2019-02-12),

13. 10131639 - Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methylcyclohexylamino)-pyrimidine-5-carboxamide (2018-11-20),

14. 10064863 - Formulations of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione (2018-09-04),

15. 10005760 - Forms and compositions of an ERK inhibitor (2018-06-26),

Title: Inventor Daozhong Zou: Pioneering Innovations in Raritan, NJ

Introduction: Daozhong Zou is a distinguished inventor based in Raritan, NJ, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Daozhong Zou holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating solutions for a better future.

Career Highlights: With a career spanning over two decades, Daozhong Zou has worked with leading research institutions and technology companies, where he has spearheaded projects that have revolutionized industries.

Collaborations: Daozhong Zou has collaborated with top universities and multinational corporations to bring cutting-edge technologies to the market, demonstrating his ability to work across disciplines and sectors.

Conclusion: Inventor Daozhong Zou's relentless pursuit of innovation and his passion for creating impactful solutions have solidified his reputation as a visionary in the field of technology.

Profile summary based on public USPTO records.